AGIO News Alert Agios Pharmaceuticals Inc (AGIO) 61.35 09/30/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Agios Pharmaceuticals Inc (AGIO) 61.35 $AGIO

Agios to Present Data on AG-120 in November, Shares Rises - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 4:30PM CDT
Shares of Agios Pharmaceuticals (AGIO) jumped 19.3% on the announcement that it will present data on AG-120 earlier than expected.

Critical Alerts For Invensense, Agios Pharmaceuticals, SPDR Gold Trust, Nu Skin Enterprises and Nike Released By InvestorsObserver
PR Newswire - Mon Sep 29, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for INVN, AGIO, GLD, NUS and NKE.

Market Maker Surveillance Report. SKY, JNS, CNET, DGLY, AGIO, SFS, Winning Stocks With Lowest Price Friction For Friday, September 26th 2014
M2 - Mon Sep 29, 2:54AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4860 companies with "abnormal" market making, 3007 companies with positive Friction Factors and 1840 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Skyline Corp (NYSE:SKY), Janus Capital Group Inc (NYSE:JNS), Chinanet Online Holdings Inc (NASDAQ:CNET), Digital Ally Inc (NASDAQ GLY), (NASDAQ:AGIO), (NYSE:SFS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

'Fast Money' Recap: Why Volatility Might Be a Good Thing
at The Street - Sat Sep 27, 4:00AM CDT
The trading panel discussed how to trade Yahoo!, Nike and biotech companies.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Sep 26, 7:14PM CDT
Cramer will be looking for more opportunities, especially ones made better by any additional volatility.

Agios drug data boosts stock
at Investor's Business Daily - Fri Sep 26, 5:52PM CDT
Biotech startup Agios Pharmaceuticals (AGIO) got a 19.3% boost to a new high of 63.76 after the company said that it would release key clinical trial data from its phase 1 study of blood cancer treatment AG-120 earlier than anticipated. It's...

Agios' Early Drug-Trial Report Cheers Wall Street
at Investor's Business Daily - Fri Sep 26, 12:21PM CDT
Shares of biotech startup Agios Pharmaceuticals (AGIO) soared 20% in the stock market today to a new high above 64 after it said it would report data from a key clinical trial earlier than expected, leading analysts to believe the news will be good....

Nasdaq stocks posting largest percentage increases
AP - Fri Sep 26, 12:17PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

Jim Cramer's Stop Trading: Does Agios Pharmaceuticals Have a Monumental Cancer Treatment?
at The Street - Fri Sep 26, 10:58AM CDT
TheStreet's Jim Cramer suggests that the only reason Agios Pharmaceuticals would present its cancer treatment data so early is if the company believes it can be monumental in the future.

Agios (AGIO) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 9:12AM CDT
Agios (AGIO) is in Overbought Territory: What’s Next?

Agios Pharmaceuticals (AGIO) Gains: Stock Up 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 7:44AM CDT
Agios Pharmaceuticals, Inc. (AGIO) was a big mover last session, as the company saw its shares rise 6.4% on the day.

Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014
Business Wire - Fri Sep 26, 6:30AM CDT
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that clinical data from a Phase 1 study of AG-120, an orally available, selective, potent inhibitor of the mutated IDH1 protein, will be highlighted in a late breaking oral presentation at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics taking place November 18 - 21, 2014, in Barcelona, Spain.

Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios
at The Street - Fri Sep 26, 6:00AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.

Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable
GlobeNewswire - Tue Sep 23, 3:05PM CDT
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced the company will webcast its presentation at the 2014 Leerink Partners Rare Disease Roundtable on Wednesday, October 1, 2014 at 3:10 p.m. EDT.

Strong On High Relative Volume: Agios Pharmaceuticals (AGIO)
at The Street - Fri Sep 19, 9:04AM CDT
Trade-Ideas LLC identified Agios Pharmaceuticals (AGIO) as a strong on high relative volume candidate

Jim Cramer's Top Stock Picks: AGIO AAPL LUV
at The Street - Wed Sep 17, 5:00AM CDT
Cramer says the charts predict a rally soon for Apple stock while Southwest remains his favorite airline.

Jim Cramer's 'Mad Money' Recap: Let's Hear It for the Bull
at The Street - Tue Sep 16, 7:20PM CDT
The markets can continue to rebound but only if a few other things go right, Cramer says.

Agios Pharmaceuticals (AGIO): Today's Weak On High Volume Stock
at The Street - Fri Sep 12, 9:08AM CDT
Trade-Ideas LLC identified Agios Pharmaceuticals (AGIO) as a weak on high relative volume candidate

Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation
GlobeNewswire - Wed Aug 13, 7:30AM CDT
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AG-221 for the treatment of patients with acute myelogenous leukemia (AML) that harbor an isocitrate dehydrogenase-2 (IDH2) mutation. AG-221 is a first-in-class, oral, selective, potent IDH2 mutant inhibitor being evaluated in a Phase 1 clinical trial in patients with advanced hematologic malignancies.

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty
Business Wire - Tue Aug 12, 12:38PM CDT
Levi & Korsinsky, LLP is investigating Agios Pharmaceuticals, Inc. (NasdaqGS: AGIO) in connection with possible claims of breaches of fiduciary duty by the board of directors of the Company.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

xFusion Tackles Cooling and Power at OCP 2026

Updated Category News Views 20

Bracing for an AI Revolution Ah, the world of AI — it's like the wild west out there, with data centers struggling to keep up as workloads skyrocket. Enter xFusion, a veteran in the computing infrastructure game, rolling out some seriously impressive tech at the 2026 Open Compute Project (OCP) Global Summit. The company's latest offering showcases how they're tackling...

Continue Reading
JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 22

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 25

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading
Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 28

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
Puori Protein Transparency Pays Off Amid Lead Scare

Updated Category News Views 17

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Continue Reading
Oracle Announces AI-Driven QuickStart Platform Launch

Updated Category News Views 27

NetSuite's AI-First Step into the Market Well, here's the NYSE stirring the pot with Oracle NetSuite's fresh announcement—an AI-first platform called QuickStart. Sounds like they've got their sights set on early-stage tech startups, banking on those little guys to plug into AI tools they've already got in their toolkit. Claude, ChatGPT—these aren't new kids on the...

Continue Reading
Truck Drivers USA & Career Driver Unveil New Driver Agent

Updated Category News Views 38

Revolutionizing Driver-Carrier Connections In today's cranking transportation scene, Truck Drivers USA (TDUSA) and Career Driver have taken a bold step to change up the driver recruitment game. They've launched what's being labeled as the first 'driver agent' within the Career Driver mobile app. It's the talk of the town in Sherwood, Arkansas, these days. This isn't just...

Continue Reading
Gourmia Introduces Ceramic-Coated Air Fryer at Costco

Updated Category News Views 19

A New Era for Home Cooking with Gourmia Stepping into the kitchen appliances arena with a dash of innovation, Gourmia has launched its first ceramic-coated air fryer, and it’s weaving its way exclusively onto the shelves of Costco. Now, it’s not just about frying anymore; it’s about adding style, efficiency, and a touch of healthy living to your countertop. But much...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 20

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 31

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading

Top 5 Most Recently Viewed Articles

PrideStaff Achieves Prestigious Ranking for Thirteenth Year

Updated Category News Views 160

PrideStaff Celebrates Remarkable Achievement PrideStaff, a well-known nationally franchised staffing organization, proudly announces its inclusion in Staffing Industry Analysts' prestigious list of the largest staffing firms in the U.S. for the thirteenth consecutive year. They have secured the #113 position on this esteemed list in their latest report. Impressive...

Continue Reading
Marelli Celebrates Triple Victory at 2025 Automotive News Awards

Updated Category News Views 298

Marelli's Outstanding Recognition at the 2025 Automotive News PACE Awards Marelli has achieved incredible recognition at the exciting 2025 Automotive News PACE Awards ceremony. The event highlighted exceptional automotive innovations, where Marelli proudly took home three prestigious awards. This remarkable achievement underlines Marelli's commitment to advancing...

Continue Reading
Quote Daddy: Free Stock Data for U.S. and Canada

Updated Category News Views 17

A Fresh Look at Stock Data Access Picture this: you're elbow-deep in trading apps, charts, and filings, and now here comes Quote Daddy, cutting through the clutter like a hot knife through butter. Market Equities Limited rolled out a new entrant in the stock-tracking game that's going for the jugular of conventional, costly market-data providers. Unveiled today, July 10,...

Continue Reading
BTR UP Unveils Innovative Tiered Investment Platform for All

Updated Category News Views 211

BTR UP Introduces a Cutting-Edge Investment Platform BTR UP, a leading digital asset investment platform managed by Btr Capital Management Inc, has launched a newly revised set of investment tiers designed to simplify entry for new investors and outline clear daily returns. With over 30 years of experience in the financial sector, Btr Capital Management has reimagined how...

Continue Reading
Exploring Dividend Insights: The Future of Ten-Year Treasury Yields

Updated Category News Views 77

Examining Future Interest Rates Through Cash Cows As we continue to look into trends in interest rates, we're bringing a new angle to our analysis. While past discussions have mostly focused on inflation and economic indicators, today we're introducing a more distinctive factor: cash cows. This concept will help us understand where dividend investors might be forecasting...

Continue Reading